Which statement is NOT part of the typical management for Stevens-Johnson syndrome/toxic epidermal necrolysis?

Prepare for the NBME Form 9 Test with our engaging quiz. Utilize multiple choice questions and explanations. Excel in your exam with thorough study tools and resources!

Multiple Choice

Which statement is NOT part of the typical management for Stevens-Johnson syndrome/toxic epidermal necrolysis?

Explanation:
The typical management of Stevens-Johnson syndrome and toxic epidermal necrolysis focuses on aggressive supportive care and meticulous wound management, usually in an ICU or burn unit setting. This means careful fluid and electrolyte balance, airway and respiratory support if needed, temperature regulation, nutritional support, infection prevention, and specialized wound care to minimize loss and prevent sepsis. Systemic steroids, while historically considered, have not shown a clear, consistent benefit in improving outcomes and can increase risks such as infection and delayed healing. Because of that, they are not part of the standard, routine management for these conditions. Some other therapies (like IVIG or cyclosporine) may be used in certain situations, but they are not universally accepted as replacements for supportive care. So the statement about systemic steroids being part of typical management is not correct.

The typical management of Stevens-Johnson syndrome and toxic epidermal necrolysis focuses on aggressive supportive care and meticulous wound management, usually in an ICU or burn unit setting. This means careful fluid and electrolyte balance, airway and respiratory support if needed, temperature regulation, nutritional support, infection prevention, and specialized wound care to minimize loss and prevent sepsis.

Systemic steroids, while historically considered, have not shown a clear, consistent benefit in improving outcomes and can increase risks such as infection and delayed healing. Because of that, they are not part of the standard, routine management for these conditions. Some other therapies (like IVIG or cyclosporine) may be used in certain situations, but they are not universally accepted as replacements for supportive care. So the statement about systemic steroids being part of typical management is not correct.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy